These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25844830)

  • 1. Interaction of depressive symptoms and smoking abstinence on delay discounting rates.
    Weidberg S; García-Rodríguez O; Yoon JH; Secades-Villa R
    Psychol Addict Behav; 2015 Dec; 29(4):1041-7. PubMed ID: 25844830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term changes in delay discounting following a smoking cessation treatment for patients with depression.
    García-Pérez Á; Vallejo-Seco G; Weidberg S; González-Roz A; Secades-Villa R
    Drug Alcohol Depend; 2020 Jul; 212():108007. PubMed ID: 32370930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased delay discounting in former cigarette smokers at one year after treatment.
    Secades-Villa R; Weidberg S; García-Rodríguez O; Fernández-Hermida JR; Yoon JH
    Addict Behav; 2014 Jun; 39(6):1087-93. PubMed ID: 24661901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No differences in delay discounting between smokers with and without HIV.
    Czuczman C; Thompson M; Wileyto EP; Schnoll R; Metzger D; Leone F; Mounzer K; Gross R; Ashare RL
    Psychopharmacology (Berl); 2021 Feb; 238(2):529-537. PubMed ID: 33180174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction effect of contingency management and sex on delay-discounting changes among treatment-seeking smokers.
    Weidberg S; Landes RD; García-Rodríguez O; Yoon JH; Secades-Villa R
    Exp Clin Psychopharmacol; 2015 Oct; 23(5):361-8. PubMed ID: 26375514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation and depressive symptoms at 1-, 3-, 6-, and 12-months follow-up.
    Rodríguez-Cano R; López-Durán A; del Río EF; Martínez-Vispo C; Martínez Ú; Becoña E
    J Affect Disord; 2016 Feb; 191():94-9. PubMed ID: 26655118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingency management effects on delay discounting among patients receiving smoking cessation treatment.
    Weidberg S; Landes RD; López-Núñez C; Pericot-Valverde I; González-Roz A; Yoon JH; Secades-Villa R
    Psicothema; 2015; 27(4):309-16. PubMed ID: 26493567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingency management for cigarette smokers with depressive symptoms.
    Secades-Villa R; Vallejo-Seco G; García-Rodríguez O; López-Núñez C; Weidberg S; González-Roz A
    Exp Clin Psychopharmacol; 2015 Oct; 23(5):351-60. PubMed ID: 26280589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal discounting and smoking cessation: choice consistency predicts nicotine abstinence in treatment-seeking smokers.
    Grosskopf CM; Kroemer NB; Pooseh S; Böhme F; Smolka MN
    Psychopharmacology (Berl); 2021 Feb; 238(2):399-410. PubMed ID: 33216166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will delay discounting predict intention to quit smoking?
    Athamneh LN; Stein JS; Bickel WK
    Exp Clin Psychopharmacol; 2017 Aug; 25(4):273-280. PubMed ID: 28627925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delay discounting by depressed and non-depressed adolescent smokers and non-smokers.
    Imhoff S; Harris M; Weiser J; Reynolds B
    Drug Alcohol Depend; 2014 Feb; 135():152-5. PubMed ID: 24360649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-perceived ability to cope with stress and depressive mood without smoking predicts successful smoking cessation 12 months later in a quitline setting: a secondary analysis of a randomized trial.
    Nohlert E; Öhrvik J; Helgason ÁR
    BMC Public Health; 2018 Aug; 18(1):1066. PubMed ID: 30153814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral activation and smoking cessation outcomes: The role of depressive symptoms.
    Martínez-Vispo C; López-Durán A; Senra C; Rodríguez-Cano R; Fernández Del Río E; Becoña E
    Addict Behav; 2020 Mar; 102():106183. PubMed ID: 31809878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual variables related to craving reduction in cue exposure treatment.
    Pericot-Valverde I; García-Rodríguez O; Gutiérrez-Maldonado J; Secades-Villa R
    Addict Behav; 2015 Oct; 49():59-63. PubMed ID: 26047836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls.
    Wing VC; Moss TG; Rabin RA; George TP
    Addict Behav; 2012 Jan; 37(1):67-72. PubMed ID: 21963152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial.
    Bernard P; Ninot G; Cyprien F; Courtet P; Guillaume S; Georgescu V; Picot MC; Taylor A; Quantin X
    J Dual Diagn; 2015; 11(3-4):205-16. PubMed ID: 26683252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers.
    Johnson MW; Bickel WK; Baker F
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):187-94. PubMed ID: 17469942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does impulsiveness moderate response to financial incentives for smoking cessation among pregnant and newly postpartum women?
    Lopez AA; Skelly JM; White TJ; Higgins ST
    Exp Clin Psychopharmacol; 2015 Apr; 23(2):97-108. PubMed ID: 25730417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroeconomic predictors of smoking cessation outcomes: A preliminary study of delay discounting in treatment-seeking adult smokers.
    Amlung M; Owens MM; Hargreaves T; Gray JC; Murphy CM; MacKillop J; Sweet LH
    Psychiatry Res Neuroimaging; 2022 Dec; 327():111555. PubMed ID: 36327864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.